Overview
Debut, based in San Diego, United States, has raised $20M in a Venture round on August 26, 2025, with participation from F-Prime Capital. The company pioneering biotech beauty. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the biotechnology research sector, Debut is positioned to capitalize on growing demand for innovative solutions in this space. The company was founded in 2019 by Joshua Britton. Joshua brings deep domain expertise and a track record of execution that attracted investor confidence in this round. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
The successful raise validates Debut's approach and market opportunity. Industry analysts note that companies at this funding stage typically grow headcount by 40-60% within 12 months and make significant technology purchasing decisions in the first quarter post-funding. This makes Debut's leadership team particularly valuable contacts for B2B outreach in the near term.
Why contact Debut now
Debut's $20M Venture raise signals serious investor confidence in their biotechnology research play. In the first 90 days post-funding, startups are 3x more likely to respond to outreach and evaluate new partnerships. Their team is hiring, their budget is unlocked, and they need solutions yesterday.
Founders & Contacts
Investors
Company Facts
| Company | Debut |
| Amount Raised | $20M |
| Funding Round | Venture |
| Date Raised | August 26, 2025 |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Founders | Joshua Britton |
| HQ Location | San Diego, United States |
Get Verified Founder Emails
Access verified email addresses and contact details for Debut's founders and thousands of other funded startups.
Start Free Trial